Cemiplimab for advanced non-small cell lung cancer: Squamous subgroup analysis for EMPOWER-Lung 1 and 3

Makharadze, T.Gogishvili, M.Melkadze, T.Baramidze, A.Sezer, A.Kilickap, S.Gumus, M.2024-05-192024-05-1920230923-75341569-8041https://doi.org10.1016/j.annonc.2023.09.2469https://hdl.handle.net/20.500.12713/5719Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- OCT 20-24, 2023 -- Barcelona, SPAIN[Abstract Not Available]eninfo:eu-repo/semantics/openAccess[No Keywords]Cemiplimab for advanced non-small cell lung cancer: Squamous subgroup analysis for EMPOWER-Lung 1 and 3Conference Object34WOS:001087480202114N/A10.1016/j.annonc.2023.09.2469